Article ID Journal Published Year Pages File Type
10963624 Vaccine 2015 8 Pages PDF
Abstract
The present post-marketing surveillance study compliant with Good Clinical Practice demonstrated the efficacy and safety of the smallpox vaccine LC16-KAKETSUKEN in an adult population. LC16-KAKETSUKEN is the sole currently available licensed smallpox vaccine for both adult and pediatric populations.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Freeze-dried live attenuated smallpox vaccine prepared in cell culture “LC16-KAKETSUKEN”: Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice
Authors
, , , , , ,